MBX Biosciences, Inc. Common Stock Working Capital to Net Assets Ratio
MBX Biosciences, Inc. Common Stock working capital to net assets ratio. MBX Biosciences, Inc. Common Stock (MBX) has a Working Capital to Net Assets ratio of 99.1% as of March 2026. Working capital of $433.97 Million (current assets of $448.54 Million minus current liabilities of $14.57 Million) is measured against net assets of $437.76 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is MBX Biosciences, Inc. Common Stock's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of MBX Biosciences, Inc. Common Stock (2022–2025)
Working capital to net assets ratio of MBX Biosciences, Inc. Common Stock from 2022 to 2025. This chart shows how MBX Biosciences, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 99.1%, reflecting working capital of $433.97 Million against net assets of $437.76 Million USD. See MBX Biosciences, Inc. Common Stock liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
MBX Biosciences, Inc. Common Stock Working Capital to Net Assets Ratio by Year (2022–2025)
MBX Biosciences, Inc. Common Stock working capital to net assets ratio by year from 2022 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for MBX Biosciences, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MBX total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.1% | $366.04 Million | $369.22 Million | $381.54 Million | $15.49 Million | ▼ -0.4 pp |
| 2024 | 99.5% | $256.24 Million | $257.44 Million | $267.29 Million | $11.05 Million | ▲ +209.3 pp |
| 2023 | -109.8% | $79.54 Million | $-72.47 Million | $83.47 Million | $3.93 Million | ▼ -14.0 pp |
| 2022 | -95.7% | $40.78 Million | $-42.60 Million | $44.21 Million | $3.43 Million | — |